Intro
Cervical cancer remains a significant health concern, ranking among the most
prevalent cancers affecting women worldwide. In 2020 alone, there were an estimated
604,127 new cases and 341,831 deaths globally ( Singh
et al., 2023 ). While persistent infection with one of approximately 15
high-risk human papillomavirus (hrHPV) types is a well-established cause of cervical
cancer ( Bosch et al., 2002 ), increasing
evidence suggests that some cervical tumors, particularly adenocarcinomas, may not
be linked to HPV infection ( Park, 2020 ). In
this sense, chronic inflammation of the cervix (cervicitis), can lead to several
adverse outcomes, including pelvic inflammatory disease, endometriosis, infertility,
and preterm birth. While cervicitis is often attributed to bacterial infections, the
presence of hrHPV sequences has been detected in some cases. Women experiencing
cervicitis concurrently with HPV infection appear to have an elevated risk of
developing low and high-grade squamous intraepithelial lesions (LSIL and HSIL,
respectively) and, ultimately, cervical cancer ( Koutsky et al., 1992 ; Fernandes et al.,
2015 ). Cancer-related chronic inflammation promotes the activation of
intracellular signaling pathways, which in turn induce numerous transcription
factors, including NF-κB, STAT, and FOXO ( Zhao et
al., 2021 ; Kim et al., 2022 ).
These transcription factors modulate the expression of a wide range of genes,
including those encoding orphan G protein-coupled receptors (oGPCRs). GPCRs are
cell-surface receptors that transmit extracellular signals into intracellular
pathways by activating heterotrimeric G proteins. While the endogenous ligands for
many orphan GPCRs remain unidentified, their importance in various diseases,
including cancer, has been clearly demonstrated ( Tang et al., 2012 ). For instance, GPR161, a negative regulator of Sonic
hedgehog (Shh) signaling during neural tube development, has been shown to play a
role in medulloblastoma. In mouse neural stem cells, suppressing GPR161 increased
downstream Shh pathway activity, leading to increased granule cell generation and
proliferation, ultimately contributing to higher tumor incidence and medulloblastoma
pathogenesis ( Shimada et al., 2018 ). GPR132
functions as a key macrophage sensor, detecting elevated lactate levels within the
acidic tumor microenvironment. This sensing plays a crucial role in mediating the
reciprocal interactions between cancer cells and macrophages during breast cancer
metastasis ( Chen et al., 2017 ). Also, GPR20
has been identified as a non-tyrosine kinase target in gastrointestinal stromal
tumor (GIST) ( Iida et al., 2021 ); meanwhile,
the GPR139 gene has been identified in glioblastoma multiforme samples ( Ren et al., 2021 ).
Therefore, this study investigated the expression of the orphan GPR161, GPR132,
GPR20, and GPR139 in samples of cervicitis, LSIL, and HSIL to elucidate their
potential roles in the pathogenesis of cervical cancer. It is important to mention
that a significant portion of the tissue samples used to carry out this study were
previously used to analyze the expression of nuclear orphan receptors of the NR4A
family and due to the results obtained by the working group, a search was carried
out for other probable biological markers in the development of cervical cancer,
obtaining new data and not published interesting results that will be analyzed and
discussed in this article ( Cruz et al.,
2024 ).
Methods
This study was approved by the Ethics and Research Committee of the Maternity
Hospital of Mexicali (registration number CDEI-0008-21). All participants
provided written informed consent before enrollment. Between January 2022 and
January 2023, 45 patients were recruited from the Medical Oncology Specialties
Unit (UNEME) in Mexicali, Baja California, Mexico. Fresh cervical tissue samples
were collected during colposcopy. Each sample was divided, with one portion used
for histopathological analysis and the other stored at -80 °C for subsequent
gene expression analysis ( Cruz et al.,
2024 ).
Total RNA was extracted from the cervical tissue samples using TRIzol® Reagent
(Thermo Fisher Scientific, USA) following the manufacturer’s protocol. The
concentration and purity of the RNA were determined by measurement of the
optical densities at 260 nm and 280 nm using a NanoDrop 1000 spectrophotometer
(Thermo Fisher Scientific, USA). An A260/A280 ratio of 1.8 or higher were
considered acceptable for these studies. These RNA samples were then diluted to
a working concentration of 1 µg/mL in nuclease-free water supplemented with
RNase inhibitor. For the reverse transcription synthesis of cDNA, the iScript
cDNA synthesis kit (Bio-Rad, USA) was used according to the manufacturer’s
instructions ( Cruz et al., 2024 ).
The primers used for PCR targeted GPR161 , GPR132, GPR20, GPR139
and GADPH ( Table 1 ).
Relative mRNA expression levels were determined using the comparative ΔΔCt
method.
Table 1 - Primer sequences used in this study .
Receptor Primers Sequences Tm(°C) GPR20 Fw GTGTCTTTGCGCTGACTGTC 56.6 Rs ATGATGCGGCCGGTAAACA 57.5 GPR132 Fw CGGAAGACAAGGAGACCTGC 50.1 Rs CGGTCAACCTGGCGTAGTAG 50.3 GPR139 Fw ATTGCCAACATGCTAGCCCT 57.3 Rs GGAACCGCTTGCTGATGAAG 56.6 GPR161 Fw CCTTGGGAGCATGTCACTGT 57.4 Rs CTTGTCCTGGTGGCTGCATA 57.4 GAPDH Fw CATCCTGGGCTACACTGAGC 57.7 Rs GTCAAAGGTGGAGGAGTGGG 57.7
The RNA extracted from cervix was reverse transcribed and used for real-time PCR
analysis with the QuantStudioTM 1 system (Thermo Fisher Scientific, USA). The
reaction mixture for PCR consisted of 5 µL of PanGreen Universal Master Mix
(Bio-Helix Ltd, Taiwan), 0.3 µL of forward primer (Integrated DNA Technologies,
USA), 0.3 µL of reverse primer (Integrated DNA Technologies, USA), 3.4 µL of
PCR-grade water, and 500 ng of cDNA template ( Cruz et al., 2024 ).
Results are presented as mean ± standard error. Statistical analysis was
performed using the Kruskal-Wallis test. A p-value of less than 0.05 was
considered statistically significant. All analyses were conducted using GraphPad
Prism (version 8.0.1).
Results
In this study, 45 tissue samples from cervices were collected from women who
underwent colposcopy and biopsy. The samples were collected from patients aged
between 15 and 60 years, with an average age of 35 years. The average age of
menarche onset was 12 years ( Cruz et al.,
2024 ). Regarding the beginning of sexual activity, it had occurred at
17 years of age on average, and 22% of the women had reported more than three
sexual partners ( Cruz et al .,
2024 ). The use of contraceptive methods, salpingoplasty and condoms
were the most used by patients ( Cruz et
al ., 2024 ). In addition, other important factors that
could have affected the health of the women in this study were the following:
Five patients were smokers, 14 were alcoholics, and one patient had reported
cocaine use. On the other hand, the body mass index indicated that 75.5% of them
had body mass indexes >30, which was compatible with overweight and obesity
( Table 2 ) ( Cruz et al ., 2024 ).
Table 2 - Demographic and clinical characteristics. Variable n = 45
Age (years)
Mean 35
Minimum 15
Maximum 60
Menarche
Mean 12
Minimum 9
Maximum 17
Onset of active sexual life
Mean 17
Minimum 15
Maximum 20
Sexual partners
1 to 3 35
> 3 10
Body mass index
No. % Low weight 0 0 Normal 11 24.4 Overweight 10 22.2 Obesity 24 53.3
Contraceptive methods
Hormonal 15 33.3 Condom 5 11.1 Salpingoplasty 25 55.5
Pap test
ASCUS 13 28.8 CIN I 21 46.6 CIN II 1 2.2 CIN III 7 15.5 Other 3 6.6
Colposcopy
Cervicitis 14 31.1 LSIL 18 40 HSIL 13 28.8 ASCUS = atypical squamous cells of undetermined significance; CIN
= cervical intraepithelial neoplasia; LSIL = low-grade squamous
intraepithelial lesions; HSIL = high-grade squamous
intraepithelial lesions.
ASCUS = atypical squamous cells of undetermined significance; CIN
= cervical intraepithelial neoplasia; LSIL = low-grade squamous
intraepithelial lesions; HSIL = high-grade squamous
intraepithelial lesions.
The results obtained from the cervical cytology were benign (atrophy or
inflammation) in 6.6% of cases, ASCUS (atypical cells of uncertain significance)
in 28.8%, cervical intraepithelial neoplasia 1(CIN I; low-grade dysplasia that
affects up to one-third of the cervical lining) in 46.6%, cervical
intraepithelial neoplasia 2(CIN II; moderate to marked dysplasia that affects up
to two-thirds of the cervical lining) in 2.2%, and cervical intraepithelial
neoplasia 3 (CIN III; severe dysplasia to carcinoma in situ
that affects the full thickness of the cervical lining) in 15.5% of the
patients. The tissue analysis of HSIL confirmed high-grade lesions, as indicated
by the cytological findings, in five cases (CIN II or CIN III). ( Table 3 ). Cervical samples for one year,
31.1% exhibited acute and chronic non-specific endocervicitis and exocervicitis,
40% exhibited LSIL, and 28.8% HSIL ( Cruz et al.,
2024 ).
Table 3 - Cervical biopsy results related to cytology results. HPR Results of cervical cytology
Benign findings ASCUS CIN I CIN II CIN III Cervicitis 12.5% (n = 2) 37.5% (n = 6) 50% (n = 6) 0 0 LSIL 10.5% (n = 1) 26.3% (n = 5) 52.6% (n=9) 0 10.5% (n = 3) HSIL 0 10% (n = 2) 70% (n = 6) 10% (n = 1) 10% (n = 4) HPR = histopathological result; ASCUS = atypical squamous cells
of undetermined significance; CIN = cervical intraepithelial
neoplasia; LSIL = low-grade squamous intraepithelial lesions;
HSIL = high-grade squamous intraepithelial lesions
[13] .
HPR = histopathological result; ASCUS = atypical squamous cells
of undetermined significance; CIN = cervical intraepithelial
neoplasia; LSIL = low-grade squamous intraepithelial lesions;
HSIL = high-grade squamous intraepithelial lesions
[13] .
Orphan receptors were expressed in cervical samples; however, their expression
changed due to the development of cervicitis or LSIL/HSIL lesions. While mRNA
expression of GPR161 showed no statistically significant difference among the
three groups (p > 0.05), mRNA of GPR132 was increased in LSIL samples
compared to both cervicitis and HSIL patients (p < 0.05). Similarly, the mRNA
of GPR20 was higher in the LSIL group compared to the cervicitis and HSIL groups
(p < 0.05). Conversely, GPR139 had diminished expression in the LSIL group, a
difference that was statistically significant (p < 0.05) compared with the
other two sample groups ( Figure 1 ).
Figure 1 - mRNA expression of the oGPRs. (A) GPR161, (B) GPR132, (C) GPR20,
and (D) GPR139 receptors in cervical biopsy samples: Cervicitis
(n=14), LSIL (n=18) and HSIL (n=13). Data were represented as mean ±
SEM. *p < 0.05.
Discussion
The role of chronic inflammation in epithelial carcinogenesis is well-established.
Studies have demonstrated a positive correlation between cervicitis and squamous
intraepithelial lesions (SILs) ( Koutsky et al.,
1992 ; Castle et al., 2001 ). SILs
are categorized into low-grade (LSIL) and high-grade lesions (HSIL), based on their
potential for progression to carcinoma. While LSIL is generally considered a
low-risk precursor to cervical cancer, it is established that both low- and
high-risk HPV can infect a broad range of cervical cell types, including columnar,
reserve, mature, intermediate, and immature squamous cells ( Pinto et al., 2010 ), producing the progression from LSIL to
HSIL, and later cervical cancer due to the interactions of several viral
oncoproteins that dysregulate cell signaling pathways involved in proliferation, DNA
damage, or repair mechanisms ( Manzo-Merino et al.,
2014 ). Among the cellular changes observed in carcinogenesis, the
modification in the expression and activity of the GPCRs, including orphan
receptors, has been described. Although oGPCRs lack identified endogenous ligands
( Jobe and Vijayan 2024 ), they exhibit
therapeutic potential in the treatment of metabolic disorders and autoimmune
diseases ( Jobe and Vijayan 2024 ). But,
specifically in cancer, they have been implicated in cellular growth and tumor
progression, making them promising targets for novel therapeutic interventions.
Therefore, the present study aimed to examine the mRNA expression of selected oGPCRs
that have been previously implicated in other types of cancer, but whose role in
cervicitis and SIL, precursors to cervical cancer, remains unexplored.
Our results showed that mRNA of oGPCRs (GPR161, GPR132, GPR20, and GPR139) are
expressed in cervical tissue, but their expression differed across cervicitis, LSIL,
and HSIL samples. Notably, GPR132 mRNA was significantly increased in LSIL samples
compared to both cervicitis and HSIL samples. This overexpression of GPR132 in LSIL
samples may represent an intrinsic compensatory mechanism to mitigate
hyperactivation of the PI3K/AKT/mTOR pathway, given the role of GPR132 activation in
promoting myeloid differentiation. Some experiments have demonstrated that the
natural agonist 8-gingerol activates the GPR132-Gs-PKA pathway, leading to the
inhibition of mTOR signaling, a critical suppressor of cell differentiation in acute
myeloid leukemia (AML). This inhibition resulted in reduced tumor growth, increased
cell differentiation, and extended mouse survival in an AML xenograft model ( Yi et al., 2022 ). While the PI3K/AKT/mTOR
pathway is crucial for physiological processes like cell survival and proliferation,
its aberrant activation contributes to tumor development ( Lim et al., 2015 ). In cervical cancer, HPV oncoproteins E6 and
E7 stimulate mTOR through the PI3K/Akt signaling cascade. This pathway exhibits a
high mutation rate in the PIK3CA gene in samples of cervical cancer, adenocarcinoma,
and squamous cell carcinomas. The loss of the phosphatase and tensin homolog (PTEN),
a key tumor suppressor and negative regulator of this pathway, frequently underlies
this dysregulation ( Bahrami et al., 2017 ).
This fact is particularly relevant considering the common progression from LSIL to
HSIL and finally cervical cancer, a process influenced by the interactions of
several viral oncoproteins that dysregulate cell signaling. This compensatory
mechanism could be crucial in early-stage disease.
Additionally, our results demonstrated that the mRNA of GPR20 was expressed in
cervical tissue, with higher expression levels observed in LSIL samples compared to
cervicitis and HSIL samples. GPR20 is a ligand-independent oGPCR, 358 amino acids in
length, that exhibits constitutive activity and is coupled to Gi protein. Its
expression is controlled by the transcription factors Forkhead box F1 (FOXF1) and
ETS variant transcriptor factor 1 (ETV1) ( Iida et
al., 2021 ). GPR20 is highly expressed in intestinal tissue and is found
with great abundance in gastrointestinal stromal tumors ( Iida et al ., 2021 ). Molecular dynamics
simulations demonstrated that GPR20 exhibits high basal activity attributed to a
non-canonical conformation of transmembrane helix 7 (TM7); this conformation brings
the N-terminal cap into the helix center, promoting its self-interaction with Gi
protein, which makes it a highly stimulated receptor. Consequently, the N-terminal
cap acts as an intrinsic agonist modulating the receptor’s signal transduction and
dynamic behavior ( Zhang et al., 2025 ).
Although GPR20 is a receptor that is highly expressed in GIST tumors, its role in
cervical cancer is not known. However, it has already been seen that GPR20 does not
have an impact on the proliferation of GIST cells, but its blockade is a potential
therapeutic target for this disease ( Iida et
al ., 2021 ). Considering that GPR20 is regulated by ETV1, its
likely implication in cancer is related to angiogenesis, given that ETV1 belongs to
the ETS family of transcription factors, which contributes to cancer progression,
activating responses of promoters to the Ras/Raf7MEK/ERK1/2 pathways ( Dittmer 2015 ).
Contrarily, the mRNA expression of GPR139 was reduced in LSIL samples. GPR139
activates several G protein pathways, with Gq/11 being the most important. For this
receptor, it has been proposed that the aromatic amino acids L-Trp and L-Phe, as
well as ACTH/α-MSH-related peptides, are endogenous agonists ( Vedel et al., 2020 ). While the mRNA of GPR139 is predominantly
expressed in the central nervous system in humans, rats, and mice ( Wang et al., 2019 ), we detected its expression
in human cervical tissue. GPR139 has been implicated in several central nervous
system mechanisms, including opioid modulation by opposing μ-opioid receptor
activity ( Stoveken et al., 2020 ), and has
been proposed as a therapeutic target for schizophrenia and drug addiction ( Mao et al., 2023 ). However, its role in cancer
remains poorly understood, but it is already known that the activation of GPR139 is
dependent on mitogen-activated protein kinase-ERK phosphorylation ( Liu et al ., 2015 ), the key
mechanism involved in the development of malignant tumors in cervical squamous
cancer tissues ( Li et al .,
2020 ). Finally, despite we detected GPR161 mRNA in cervical tissue, we
observed no significant differences in its expression across cervicitis, LSIL, and
HSIL samples. This suggests that GPR161 expression is not modulated during the
development of these cervical lesions and may not contribute to their
progression.
Conclusions
GPR132, GPR20, and GPR139 expression was modified in LSIL samples compared to
cervicitis and HSIL samples. Given the involvement of the signalling pathway of
these receptors in several types of cancer, we proposed that their differential
regulation in LSIL may represent a mechanism to prevent the progression to HSIL and
later cervical cancer. Therefore, further exploration of oGPCRs could be crucial for
identifying novel therapeutic targets for cervical cancer treatment.
Data Availability
The data that support the findings of this study are available from the
corresponding author [ARH] on reasonable request.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.